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Abstract:  Previously, we reported α2-macroglobulin (α2M) to be a novel marker characteristic of rat hepatocellular
preneoplastic and neoplastic lesions negative for hitherto well-established markers.  In the present study, we further
examined other candidate markers with specificity for the same type of lesions.  Glutathione S-transferase-placental form
(GST-P)-negative hepatocellular altered foci (HAF) were generated using a two-stage (initiation and promotion)
carcinogenesis protocol with N,N-diethylnitrosamine (DEN) and either Wy-14,643 or clofibrate, two peroxisome
proliferators.  Microarray analysis using total RNAs isolated from laser-microdissected GST-P-negative HAF
(amphophilic cell foci) and adjacent normal tissues was conducted along with immunohistochemistry and real-time RT-
PCR.  Staining for glucose-regulated protein 78 (GRP78) was detected in GST-P-negative HAF and hepatocellular
adenomas, and slightly increased GRP78 mRNA expression was observed in the lesions by real-time RT-PCR analysis.
Thus, an early increase of GRP78 expression in hepatocarcinogenesis is likely a feature of the amphophilic subset of
HAF.  (J Toxicol Pathol 2009; 22: 281–288)
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Introduction
During the process of rat hepatocarcinogenesis, a small
proportion of preneoplastic lesions, hepatocellular altered
foci (HAF), develop into hepatocellular adenomas (HCAs)
and hepatocellular carcinomas (HCCs).  While many HAF
regress following withdrawal of a proliferative stimulus1–4,
others may persist and demonstrate stable growth5,6.  The
molecular mechanisms underlying these phenomena,
however, are unclear.  Although foci possess some
phenotypic diversity7, there are markers that allow detection
in the majority of cases.  However, while γ-glutamyl
transpeptidase (γ-GT)3,4,6–11 and particularly glutathione S-
transferase-placental type (GST-P)12,13 have become
established as marker enzymes for hepatocarcinogenesis in
rats, they have shortcomings regarding detection of
basophilic and amphophilic cell foci, especially those
induced by peroxisome proliferators14–16.  Amphophilic cell
foci, characterized by increased granular acidophilia and
diffusely scattered cytoplasmic basophilia, demonstrate
alterations in mitochondrial enzymes16,17, but cytochemical
markers applicable to routine detection of γ-GT and/or GST-
P-negative foci, especially small lesions not evident in
routine hematoxylin-eosin (HE) staining, have been lacking.
In our previous study, α2-macroglobulin (α2M) was
identified as a novel cytochemical marker characterizing
preneoplastic and neoplastic rat liver lesions composed of
amphophilic or basophilic cells18.  A previous investigation
revealed this typical member of the pan-proteinase inhibitor
α2M family to be upregulated in human serum during HCC
development19.  It was also found overexpressed in HCCs
due to hepatitis C virus infection as compared with
nontumorous liver tissues20.  Moreover, Pizzo’s group
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reported that an activated form of α2M (α2M*) is able to
modulate cell proliferation via a distinct cell surface
receptor, the 78-kDa glucose-regulated protein (GRP78)21.
GRP78 is well known as the major sensor of
endoplasmic reticulum (ER) stress and recently has attracted
attention as a promising target for cancer therapy, since it
makes a contribution to tumor progression by inhibition of
apoptosis22.  The majority of GRP78 molecules reside in the
lumen of the ER, but a subpopulation exists as an ER
transmembrane protein on the surfaces of some cells, such as
certain cancer cells and growth-stimulated endothelial
cells22.
In the present study, we demonstrated that GRP78 is
characteristically upregulated from an early stage of rat
hepatocellular carcinogenesis, specifically in GST-P-
negative lesions.  The results suggest that an early increase
of GRP78 expression in hepatocarcinogenesis is likely a
feature of the amphophilic subset of HAF.
Materials and Methods
Animals
A total of 50 male, 5-week-old F344 rats were
purchased from Charles River Japan Inc.  (Atsugi, Japan)
and housed in suspended aluminium cages (three rats per
cage) in a room kept at 24 ± 2°C and 40–70% humidity with
a 12-h light/dark cycle.  Drinking water was available ad
libitum.  They received CRF-1 Laboratory Chow (Charles
River Japan Inc.) as basal diet in experiments 1 and 2 ad
libitum.  The animals were observed daily and were used for
the experiments after a 1-week acclimation period.  Body
weight was measured every week18.
Chemicals
N,N-diethylnitrosamine (DEN) and clofibrate (> 98%)
were purchased from Tokyo Kasei Kogyo Co., Ltd. (Tokyo,
Japan), and Wy-14,643 (> 98%) was obtained from
ChemSyn Laboratories (Lenexa, KA, USA).
Experimental protocol
All experiments were performed in accordance with the
Guide for Animal Care and Use of Sumitomo Chemical Co.,
Ltd.  In Experiment 1, an in vivo rat liver medium-term
bioassay for carcinogens was conducted13, with a minor
modification in regard to the treatment period for the
peroxisome proliferators.  Briefly, at the age of 6 weeks, 20
male F344 rats were divided into four groups (5 animals per
group).  The animals were given a single intraperitoneal
injection of DEN (200 mg/kg body weight) dissolved in
saline to initiate hepatocarcinogenesis and after a 2-week
recovery period received clofibrate (3,000 ppm, Group 1) or
Wy-14,643 (1,000 ppm, Group 2) in the basal diet.  The rats
were subjected to two-thirds partial hepatectomy (PH) in
week 3.  The animals in Group 3 were given DEN and PH in
the same manner as for Groups 1 and 2 without
administration of any other chemicals, and the animals in
Group 4 were treated in the same manner as Group 3, except
that they were injected with saline instead of DEN.  All
animals were sacrificed at week 12.
In Experiment 2, an initiation-promotion model was
used in which the number of administrations of DEN was
increased in place of PH in Experiment 1.  Judging from our
experience, however, the dose of DEN was set at 100 mg/kg
so as to not impose too heavy a burden on the animals.
Briefly, 30 male, 6-week-old, F344 rats were divided into
three groups (10 animals per group).  The animals in Groups
1 and 2 were injected with DEN (100 mg/kg body weight)
intraperitoneally once a week for 2 weeks and after a one-
week recovery period received clofibrate (3,000 ppm, Group
1) or the basal diet (Group 2).  The animals in Group 3 were
injected with saline instead of DEN solution without
subsequent administration of any chemicals.  Sacrifice was
at weeks 26 and 36.
In both experiments, all animals in each group were
exsanguinated and sacrificed under ether anesthesia, and the
liver tissues were obtained and treated with appropriate
procedures for the following examinations.
Laser microdissection (LMD) and total RNA isolation
Frozen liver tissues embedded in OCT compound
(Sakura Finetech, Tokyo, Japan) were sectioned at about 8
μm to obtain several sets of 7 serial sections, and the first and
last sections in each suite were applied to routine HE
staining and immunohistochemical staining for rat GST-P to
identify microlesions histopathologically for
microdissection.  The remaining sections were treated to
block degradation of RNA, i.e., the sections were fixed in
70% ethanol for 1 min, immersed in RNase-free
hematoxylin for 5 min, rinsed in RNase-free water several
times, immersed in RNase-free PBS for 5 min and immersed
in RNase-free eosin for 1 min.  In experiment 1, GST-P-
positive and GST-P-egative HAF and corresponding
adjacent normal tissues were microdissected using a laser
microdissection system (Leica Microsystems Japan, Tokyo,
Japan) from the following groups: GST-P-positive HAF in
Groups 1 and 3 and GST-P-negative HAF in Group 2.  In
experiment 2, HAF, HCA, HCC and corresponding adjacent
normal tissues were microdissected in the same manner from
the following groups: GST-P-negative HAF in Group 1 and
GST-P-negative and GST-P-positive HCA and HCC in
Group 1.  In each experiment, 4 foci from Group 1, 23 foci
from Group 2 and 6 foci from Group 3 in experiment1 and 3
foci from Group 1 in the respective experiment were pooled,
since the sizes of HAF were not sufficient to obtain a large
enough total quantity of RNA from each lesion.
Subsequently, total RNAs were isolated from the
microdissected tissues in accordance with the
manufacturer’s instructions for the RNeasy Protect Mini Kit
(QIAGEN, Tokyo, Japan) with a minor modification
consisting of use of poly (C) (Amersham Bioscience,
Buckinghamshire, UK) as a carrier.  The total RNA pool was
used for the subsequent microarray analysis and RT-PCR
assays.Sukata, Uwagawa, Ozaki et al. 283
High-density oligonucleotide microarray analysis
Rat Genome U34A Array chips containing 9,000
probes for known rat genes or Expressed sequence tags
(ESTs) were purchased from Affymetrix (Santa Clara, CA,
USA).  For microarray probing, reverse transcription,
second-strand synthesis and probe generation were all
accomplished following the technical notes of the Small
Sample Labeling Protocol Ver.#2 (Affymetrix).  Briefly,
first-strand cDNA was synthesized from 100 ng of total
RNA with SuperScript II reverse transcriptase (Invitrogen,
Tokyo, Japan) and a T7-(dT)24 primer (Amersham
Bioscience, Buchinghamshire, UK), and then double-
stranded cDNA was synthesized with E.coli RNase H, E.coli
DNA polymerase I and E.coli DNA ligase (Invitrogen).
From this double-stranded cDNA, cRNA was prepared using
a MEGAscript T7 Kit (Ambion, Austin, TX, USA).  After a
second cycle of amplification and biotin-labeling with a
BioArray High Yield RNA Transcript Labeling Kit (Enzo
Diagnostics, Farmingdale, NY, USA), 20 μg of labeled
cRNA was fragmented.  The RGU34A arrays were
hybridized as described in the Gene Chip Expression
Analysis Technical Manual (Affymetrix) and stained for use
with a GeneArray scanner (Agilent Technologies, Palo Alto,
CA, USA).  The derived signal value was globally
normalized and targeted to all probe sets equal to 100 before
comparative analysis.
Microarray data analysis
To examine gene expression differences between GST-
P-negative or GST-P-positive HAF and the corresponding
adjacent normal tissue, we performed a comparison analysis
using the Affymetrix data suite system, MAS 5.0.  The genes
(probe sets) showing greater than two-fold alterations in
their values, increases or decreases, were selected as
changed genes.
TaqMan real-time RT-PCR of GRP78 mRNA in GST-
P-negative HAF
TaqMan real-time RT-PCR of GRP 78 mRNA was
performed in accordance with a standard protocol and
standard TaqMan thermocycling conditions using the same
RNA samples as them applied to microarray analysis.  The
PCR primer and TaqMan probe sequences for rat GRP78
mRNA were as follows: forward primer, 5’-CAC GTC CAA
CCC GGA GAA-3’; reverse primer, 5’-TTC CAA GTG
CGT CCG ATGA-3’; probe, 5’-ACC GTC TTC GAC GCC
AAG CGC-3’.  Primers and the TaqMan probe for rat
GAPDH were purchased (Invitrogen, Tokyo, Japan).
Immunohistochemistry for GRP78 and GST-P
Immunohistochemical staining for GRP78 and GST-P
was performed on consecutive 4% paraformaldehyde-fixed
liver sections from animals in experiment 2.  Staining for
GST-P was conducted as in our previous study18.  That for
GRP78 was accomplished in accordance with the protocol
provided in the CSA II Kit (Dako Japan, Tokyo), with a
minor modification consisting of retrieval of antigens using
Target Retrieval Solution (Dako Japan), using a primary
goat anti-GRP78 antibody (1:1000, room temperature, 15
min, Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA).  The negative control was prepared by withdrawal of
the 1st antibody to validate the specificity in each
immunohistochemical staining.
Results
Histopathology and laser microdissection
Histopathological examination was conducted with
reference to earlier articles16,22 and a diagnostic guide23, and
the results are shown in Table 118.  Several frozen cell
populations were harvested, specifically from GST-P-
positive and/or GST-P-negative HAF, HCAs and HCCs,
using laser microdissection, and total RNA was isolated
from each lesion in experiments 1 and 2.  GST-P-negative
HAF, i.e., amphophilic cell foci, were not clearly detectable
in the frozen sections stained by HE in Group 1 of
experiment 1, so amphophilic GST-P-negative HAF were
microdissected from Group 2 in experiment 1 and Group 1 in
experiment 2.
Table 1. Histopathological Findings in the Liver
Experiment 1 Experiment 2
Breeding term 12 weeks 26 weeks 36 weeks
Histopathological findings* Group# 1 234 123 1 2 3
No. of animals examined 5 5 5 5 5 5 5 5 5 5
Centrilobular hepatocellular hypertrophy + 5 0 0 0 0 0 0 0 0 0
2 + 05 0 000 0 0 0 0
Hepatocellular altered foci 5a 5b 5a 05 c 5d 05 c 5d 1e
Hepatocellular adenoma 0 0 0 0 3 0 0 2 2 0
Hepatocellular carcinoma 0 0 0 0 2 0 0 4 1 0
* Grading: +–, slight; +, mild; 2+, moderate; 3+, severe.  # Experiment 1: 1, DEN→clofibrate; 2, DEN→Wy-14,643; 3, DEN alone; 4, no
treatment.  Experiment 2: 1, DEN→clofibrate; 2, DEN alone; 3, no treatment.  a Predominantly clear cell foci and small numbers of amphophilic
cell foci.  b Amphophilic cell foci and clear cell foci.  c Clear and acidophilic cell foci and amphophilic cell foci.  d Predominantly clear and
acidophilic cell foci and a small number of amphophilic cell foci.  e Clear cell foci.284 Upregulation of GRP78 in Rat Hepatocarcinogenesis
Expression of mRNA
GST-P-negative HAF induced by DEN→Wy-14,643
(experiment 1) or DEN→clofibrate (experiment 2), and
GST-P-positive HAF induced by DEN alone or
DEN→clofibrate (Experiment 1) were compared with the
corresponding respective adjacent normal tissues.  As a
result of microarray analysis, while α2M was successfully
identified in preneoplastic and neoplastic rat liver lesions
negative for GST-P18, fluctuation of GRP78, which can play
a role as a receptor for α2M* when located on the cell
surface, was not observed in the same lesions (Table 2).
Furthermore, mRNAs for other genes related to ER stress
and /or hypoxia, as well as GRP78, did not show abnormal
expression in GST-P-negative HAF (Table 3).  However,
slight enhancement of GRP78 mRNA was observed only in
GST-P-negative HAF induced by DEN→clofibrate by real-
time RT-PCR analysis, even though the levels of GRP78
mRNA in the normal tissues were different between
experiments 1 and 2 (Fig. 1).
Immunohistochemical analysis: Immunohistochemical
analyses revealed characteristic signals for GRP78 in GST-
P-negative HAF and HCA induced by DEN→clofibrate
(Figs. 2 and 3), although the positive intensity was too weak
to identify the intensity clearly in some of the small GST-P-
negative HAF.  On the other hand, GRP78 did not appear to
be upregulated in GST-P-negative HAF induced by
DEN→Wy-14,643 (data not shown).
Discussion
In the present study, an increase in
immunohistochemical staining for GRP78 was
characteristically observed in GST-P-negative HAF induced
by DEN→clofibrate, and slightly increased GRP78 mRNA
expression was also observed in the lesions.  These results
are in line with previous reports showing that GRP78, a
major molecular ER chaperone, is induced in a wide variety
of human cancers24,27.
While Hung et al. reported that ER stress can stimulate
COX-2 expression through the NF-κB and p38 kinase
pathways28, GST-P-negative HAF positive for GRP78 may
not necessarily be characterized by hypoxic conditions, since
Table 2. GRP78 mRNA Expression Based on Microarray Analysis
GST-P negative lesion
DE→WYa DEN→CFb
Microdissected lesion Signalsc Ratiod Signals Ratio
Hepatocellular altered foci 36.7 1.0 8.6 0.1
Hepatocellular adenoma NEe NEe 7.0 0.1
Hepatocellular carcinoma NEe NEe 18.5 1.5
a WY: Wy-14,643.  b CF: Clofibrate.  c Signals indicate intensity of gene expression.  d The ratio
represents the log2 of the ratio between the foci and adjacent normal liver tissue samples.  e Not examined.
Table 3. mRNA Expressions of Genes Related to Hypoxia or ER Stress in GST-P Negative HAF
DEN→WYa DEN→CFb
Genes Accession no.  Signals Ratiod  Signalsc Ratiod 
Hypoxia inducible factor 1 Y09507 5.5 –0.3 10.4 0.9
Hypoxia induced gene 1 AA891422 260.1 0.1 161.1 0.1
GRP94 S69315 78.3 –0.2 66.5 –0.2
GRP75 S78556 705.8 –0.4 415.0 0.1
These data are based on the microarray analysis.  a WY: Wy-14,643.  b CF: Clofibrate.  c Signals indicate
the intensity of gene expression.  d The ratio represents the log2 of the ratio between the foci and adjacent
normal liver tissue samples.
Fig. 1. The relative expression of GRP78 mRNA in GST-P-negative
HAF induced by DEN→clofibrate was slightly increased
compared with the adjacent normal tissue.  The vertical axis
represents the ratio of GRP78 mRNA expression versus
GAPDH mRNA expression in each region. The white bars
represent GRP78 mRNA expression in the normal tissue, and
the left hatched and black bars represent GST-P-positive and
GST-P-negative HAF, respectively.Sukata, Uwagawa, Ozaki et al. 285
mRNAs of genes related to hypoxia and/or ER stress, such as
Hypoxia inducible factor 1α, Hypoxia induced gene 1,
GRP94 and GRP75, were not upregulated according to the
cDNA microarray analysis.
It has been reported that GRP78 located on the cell
surface can play a role as a receptor for circulating
autoantibodies against GRP78 and α2M* and modulate
intracellular signal cascades, for instance, leading to an
inositol 1,4,5-trisphosphate-dependent increase in Ca2+ and
activation of Ras/mitogen-activated protein kinase-
Fig. 2. Immunohistochemistry for GRP78 and GST-P in HAF induced by DEN→clofibrate. (a) GST-P-negative lesion: 1, HE staining;
2, GRP78; 3, GST-P. (b) GST-P positive lesion: 1, HE staining; 2, GRP78; 3, GST-P. Lens × 4.286 Upregulation of GRP78 in Rat Hepatocarcinogenesis
dependent signaling29–33.  We previously observed
upregulation of α2M mRNA in GST-P-negative HAF18, so
control of their expression may be coordinated.  Although
α2M protein was not always immunohistochemically
detectable in GST-P-negative foci, in contrast with α2M
mRNA18, this might be explained by the short half-life of
α2M*, i.e., <2 minutes34.  In the present study, GRP78 was
not detectable immunohistochemically in GST-P-negative
HAF induced by DEN→Wy-14,643 (data not shown), in line
with the result from RT-PCR, but this might be because the
lesions were generally very small.
According to our preliminary data, no characteristic
immnohistochemical staining of GRP78 was observed in
GST-P-positive HAF induced by DEN→DDT or sodium
phenobarbital, however, GRP78 is observed in HCCs
occurring spontaneously in TGFα transgenic mice.  This
may point to a characteristic accumulation of GRP78 in ER
stress due to the microenvironment of the HCC.  Whatever
the case, the results do suggest that accumulation during
hepatocarcinogenesis is independent of the species, at least
in HCCs.
In conclusion, the present study provides the first
evidence that GRP78 is upregulated even in early lesions,
such as HAF in rat hepatocarcinogenesis.  However, much
remains to be learned before we can determine the
mechanistic implications and feasibility of its use as a
marker.
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